How to use COVID-19 antiviral drugs in patients with chronic kidney disease
Antiviral drugs such as Remdesivir (Veklury), Nirmatrelvir with Ritonavir (Paxlovid), Azvudine, and Molnupiravir (Lagevrio) can reduce the risk for severe and fatal Coronavirus Disease (COVID)-19. Although chronic kidney disease is a highly prevalent risk factor for severe and fatal COVID-19, most c...
Saved in:
Main Authors: | Ajinath Kale (Author), Vishwadeep Shelke (Author), Neha Dagar (Author), Hans-Joachim Anders (Author), Anil Bhanudas Gaikwad (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling
by: Sudhan Rackimuthu, et al.
Published: (2021) -
Primary primitive neuroectodermal tumor of the kidney
by: Sunil Vitthalrao Jagtap, et al.
Published: (2018) -
How to compare antivirals in the treatment of chronic hepatitis B?
by: Leblebicioglu Hakan, et al.
Published: (2009) -
Effectiveness of Antiviral Drugs as Covid-19 Therapy
by: Adelia Firandi, et al.
Published: (2021) -
COVID-19 in Children Managed Without Antiviral Drugs
by: Mohammad Sadegh Rezai, et al.
Published: (2021)